Ella Visit 1: An Inner-City Police Officer Recently Transferred to the Night Shift
| Title: | Ella Visit 1: An Inner-City Police Officer Recently Transferred to the Night Shift |
| Topic: | Sleep Disorders |
| Relevant Terms: | Insomnia, Shift Work Disorder, Sleep Disorders |
| Primary Audience: | Primary Care Physicians, Family Physicians, Internal Medicine Physicians, Occupational Medicine Specialists, Nurse Practitioners, and Physician Assistants |
| Launch Date: | 08-Jan-09 |
| Credits: | 0.5 AMA PRA Category 1 Credit™ 0.5 AANP contact hour of continuing education |
| Expiration Date: | The accreditation for this activity has expired. |
Learning Objectives
After completion of this activity, participants should be better able to:
- Consistently ask patients about work/sleep hours, sleep habits, and sleep hygiene to screen for those who may be at risk for shift work disorder (SWD).
- Identify patients who require referral to sleep centers for definitive diagnosis and management of SWD.
- Design management plans for SWD tailored to individual patients, accommodating their personal schedules and medical profiles.
- Describe potential liability issues and the responsibilities incumbent upon clinicians to recognize and manage SWD in their patients.
Faculty
Michael J. Thorpy, MD
Director, Sleep-Wake Disorders Center
Montefiore Medical Center
Professor of Neurology
Albert Einstein College of Medicine
Bronx, New York
Consultant: Laura K. Barger, PhD
Instructor in Medicine
Harvard Medical School
Associate Physiologist
Division of Sleep Medicine
Brigham and Women’s Hospital
Boston, Massachusetts
DISCLOSURE OF CONFLICTS OF INTEREST In accordance with the Accreditation Council for Continuing Medical Education (ACCME), the Dannemiller Memorial Educational Foundation requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest. Please refer to individual faculty disclosure of conflicts of interest listed below.
Michael J. Thorpy, MD, reported the following financial interests/relationships or affiliations with commercial interests related to the content of this CME activity:
- Speaker Bureaus: Cephalon, Inc.; Jazz Pharmaceuticals, Inc.; Sanofi-Aventis; Sepracor, Inc.; Takeda Pharmaceuticals North America, Inc.
- Consulting Fees (e.g. Advisory Boards): Cephalon, Inc.; Jazz Pharmaceuticals, Inc.; Sanofi-Aventis; Sepracor, Inc.; Takeda Pharmaceuticals North America, Inc.
Laura K. Barger, PhD, has no conflicts of interest to report.
The Dannemiller staff and Vital Issues in Medicine (VIM®) staff that were involved in the development of this activity have no financial relationships with any commercial interests that are relevant to this activity.
William Yarnall, RPh, CCP, Medical Director for VIM, has nothing to disclose.
To resolve identified conflicts of interest, the educational content was fully peer-reviewed by a physician member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.
DISCLOSURE OF UNLABELED OR INVESTIGATIONAL DRUGS This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should critically appraise the information presented and are encouraged to consult appropriate resources for any product or device mentioned in this program.
DISCLAIMER The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of the Dannemiller Memorial Educational Foundation; Cephalon, Inc.; or Vital Issues in Medicine. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.
ACKNOWLEDGEMENT This activity is supported by an educational grant from Cephalon, Inc.
ACCREDITATION AND CREDIT DESIGNATION This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Dannemiller Memorial Educational Foundation and Vital Issues in Medicine (VIM®). The Dannemiller Memorial Educational Foundation is accredited by the ACCME to provide continuing medical education for physicians.
Physicians The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners This program has been approved for 0.5 contact hours of continuing education by the American Academy of Nurse Practitioners. Program ID 0812591.
To Obtain CME Credits This activity includes text and graphics and may include multimedia features. Click on all of the medical education activity links and review the content presented.
- Read, complete, and submit answers to the examination and evaluation questions online.
- You must score 70% or higher to receive credit for this activity.
- Once you have successfully completed the examination and evaluation, a certificate will be automatically generated.
COURSE VIEWING REQUIREMENTS
| PC Internet Explorer (v6 or greater), or Firefox |
MAC Safari |
Release Date: January 8, 2009
Expiration Date: January 8, 2010
This continuing medical education activity is jointly sponsored by the Dannemiller Memorial Educational Foundation and Vital Issues in Medicine, A PDI Company.
| 
|  |
